Bipolar Disorder Market Size & Share is Expected to reach USD 5.56 Billion by 2030, to grow at a CAGR of 3.1%

Click here to view original web page at Bipolar Disorder Market Size & Share is Expected to reach USD 5.56 Billion by 2030, to grow at a CAGR of 3.1%

“According to the research report published by Polaris Market Research, the global bipolar disorder market was valued at USD 4.28 billion in 2021 and is expected to reach USD 5.56 billion by 2030, to grow at a CAGR of 3.1% during the forecast period.” What is New Additions in […]

Top January 2023 FDA Approvals

Click here to view original web page at Top January 2023 FDA Approvals

Adacel is administered as a single 0.5-mL intramuscular injection. To start the New Year, the US Food and Drug Administration (FDA) has approved drugs relevant to conditions often treated by nurse practitioners and PAs. Approvals include treatments for schizophrenia and bipolar disorder, pertussis, Alzheimer disease, and type 2 diabetes. […]

Childhood, Adolescent Cancers Linked to Higher Risk of Major Psychiatric Disorders

Click here to view original web page at Childhood, Adolescent Cancers Linked to Higher Risk of Major Psychiatric Disorders

Cancer survivors had an increased risk of autism spectrum disorder, ADHD, PTSD, OCD, major depressive disorder, and bipolar disorder. Compared with the general population, survivors of childhood and adolescent cancers have an increased risk of 6 major psychiatric disorders, according to a study published in the Journal of Clinical […]

FDA approves Luye Pharma’s Rykindo for the treatment of schizophrenia and bipolar 1 disorder

Click here to view original web page at FDA approves Luye Pharma’s Rykindo for the treatment of schizophrenia and bipolar 1 disorder

FDA approves Luye Pharma’s Rykindo for the treatment of schizophrenia and bipolar 1 disorder PRINCETON, N.J., Jan. 15, 2023 /PRNewswire/ — Luye Pharma Group (Luye Pharma), an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications, today announced that the U.S. Food and Drug Administration […]

Psychedelic therapies make inroads in the American West

Click here to view original web page at Psychedelic therapies make inroads in the American West

In several states, compounds in hallucinogenic mushrooms are being used to treat Parkinson’s, bipolar disorder, chronic pain and other diseases Participants receive training to become state-certified psilocybin facilitators, in Portland, Oregon on December 2, 2022.Amanda Lucier (ContactoPhoto) Psilocybin – a compound in hallucinogenic mushrooms – is taking the Western […]

How differences in diagnoses of mental disorders might affect clinical research outcomes for antipsychotics

Click here to view original web page at How differences in diagnoses of mental disorders might affect clinical research outcomes for antipsychotics

Patients with bipolar disorder who exhibited psychotic features derived a clear benefit from antipsychotic drugs (a) but not from mood stabilizers (b). Credit: Taro Kishi, Fujita Health University School of Medicine Most physical disorders such as heart disease or muscular dystrophy have well-defined boundaries. Clinicians from across the globe […]

How differences in diagnoses of mental disorders might affect clinical research outcomes for antipsychotics

Click here to view original web page at How differences in diagnoses of mental disorders might affect clinical research outcomes for antipsychotics

Mental illnesses often have unclear definitions, and their diagnosis and treatment are susceptible to subjective interpretation. Japanese researchers have now clarified an important confounding factor in the evaluation of antipsychotics Peer-Reviewed Publication Fujita Health University image: Patients with bipolar disorder who exhibited psychotic features derived a clear benefit from […]

How differences in diagnoses of mental disorders might affect clinical research outcomes for antipsychotics

Click here to view original web page at How differences in diagnoses of mental disorders might affect clinical research outcomes for antipsychotics

Patients with bipolar disorder who exhibited psychotic features derived a clear benefit from antipsychotic drugs (a) but not from mood stabilizers (b). Credit: Taro Kishi, Fujita Health University School of Medicine Most physical disorders such as heart disease or muscular dystrophy have well-defined boundaries. Clinicians from across the globe […]

7 Nutrient-Packed Foods for People With Bipolar Disorder

Click here to view original web page at 7 Nutrient-Packed Foods for People With Bipolar Disorder

Certain nutrients found in citrus fruits, nuts, and seafood may be beneficial for people with bipolar disorder, experts say. Someone with bipolar disorder — formerly known as manic depression — typically experiences extreme shifts in mood and energy levels. These shifts alternate between periods of feeling extremely upbeat, elated, […]

The Bipolar Spectrum: The Different Types of Bipolar Disorder

Click here to view original web page at The Bipolar Spectrum: The Different Types of Bipolar Disorder

Bipolar disorder is a serious clinical entity that often generates bewilderment and fear. In addition, there are up to nine different forms of bipolar disorder. In this article, we’re going to explain the different types. Bipolar disorder is a serious and disabling clinical entity . Its onset usually occurs […]